Statistics
Publications
10
Citations
8K
H-Index
10
Active since
2010
Michal Barzily-Rokni is an author at Massachusetts General Hospital specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2010–2022
10
10
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text
Life Sciences, Immunology, Oncology +14
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman, Teppei Morikawa, Kevin Shee et al. · Nature · 2012 · 1.7K citations · Full text
Medicine, Cancer Biology, Oncology +15
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J. Jiao, Jonathan Chen et al. · Nature Communications · 2017 · 1K citations · Full text
Medicine, Immunology, Oncology +17
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations
Medicine, Immunology, Oncology +17
1–5 of 10